RedHill Biopharma (RDHL) Event June 01, 2022, 12:00 UTC (10% Negative) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 2:10 p.m. 🌍 RedHill Biopharma (RDHL) - Form 6-K Filing Filing Date: 2022-06-01 Accepted: 2022-06-01 08:00:13 Event Type: Clinical Trial Update Event Details: Apogee Biotechnology Corp. and RedHill Biopharma Ltd. have entered into an exclusive license agreement. Apogee wishes to license to RedHill all Apogees rights in and to ABC294640 and (as those terms are defined below) 💼 Business Developments: ✅ Partnership/Collaboration✅ Acquisition Activity✅ Licensing Agreement✅ Regulatory Milestone❌ Leadership Updates: Not reported
🌍 RedHill Biopharma (RDHL) - Form 6-K Filing
Filing Date: 2022-06-01
Accepted: 2022-06-01 08:00:13
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments: